Dan Mallor
Head of Investor Relations
Replay available
BeOne Medicines Ltd. (ONC) Q2 2025 Earnings Call
BeOne Medicines Ltd. (NASDAQ: ONC) Q2 2025 earnings conference call, held 2025-08-06. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
John Euler
Co-Founder, Chairman and CEO
Aaron Rosenberg
Chief Financial Officer
Lai Wang
Global Head of R&D
Mark Lanasa
Chief Medical Officer, Solid Tumors
Matt Chalas
General Manager, North America
Jessica Fye
Analyst at J.P. Morgan
Sean Larmann
Analyst at Morgan Stanley
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Beone Medicines Ltd. Class A.
Replay transcript excerpt
WEBVTT 00:00:00.000 -- 00:00:05.120 Good day everyone. Welcome to B1 Q2 2025 00:00:05.120 -- 00:00:07.640 earnings call webcast. 00:00:07.640 -- 00:00:12.260 All lines have been placed on mute to prevent any background noise. 00:00:12.260 -- 00:00:16.400 After the speaker's remarks there will be a question and answer session. 00:00:16.400 -- 00:00:21.480 At this time I would like to turn the call over to the company. 00:00:23.920 -- 00:00:26.540 Hello and welcome. Thanks for joining us today. 00:00:26.540 -- 00:00:30.280 I'm Dan Mallor head of investor relations at B1 Medicines. 00:00:30.280 -- 00:00:34.500 Before we begin please note that you can find additional materials including a replay 00:00:34.500 -- 00:00:39.300 of today's webcast and presentation on the investor relations section of our website 00:00:39.300 -- 00:00:41.300 .B1Medicines.com. 00:00:42.800 -- 00:00:46.560 I would like to remind all participants that during this call we may make forward-looking 00:00:46.560 -- 00:00:52.340 statements regarding among other things the company's future prospects business strategy. 00:00:52.340 -- 00:00:56.720 Actual results may differ materially from those indicated and the forward statements 00:00:56.720 -- 00:01:01.660 has resulted various factors including those risks discussed in our most recent periodic 00:01:01.660 -- 00:01:04.160 report filed with the SEC. 00:01:04.160 -- 00:01:08.100 Please also carefully review the forward-looking statements disclaimer in the slide deck 00:01:08.100 -- 00:01:11.460 that accompanies this presentation. 00:01:11.460 -- 00:01:15.680 Reconciliation between gap and non-gap financial measures discussed on this call provided 00:01:15.680 -- 00:01:20.200 in the appendix to our presentation which is posted to our investor relations ...